We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically infected patients. The overall agreement rate between assays was 94.2% and 98.8% for the detection of PC and BCP mutations, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.diagmicrobio.2017.12.006 | DOI Listing |
Publication Analysis
Top Keywords
sanger sequencing
8
inno-lipa® hbv
8
assay routine
8
routine detection
8
detection precore
8
precore basal
8
basal core
8
core promoter
8
mutations hepatitis
8
hepatitis virus
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!